Rexahn completes direct public offering

Rexahn Pharmaceuticals Inc. (NYSE-M:RNN), Rockville, Md. Business: Cancer, Neurology, Genitourinary Date completed: 7/24/13 Type: Direct public offering Raised: $5.7 million Units: 11.4 million Price:...